-
Electrophoresis Market by Product (Gel Electrophoresis, Geldoc, Imaging, Capillary Electrophoresis, Reagents), Application (Quality Control, Diagnostic, Reasearch), End User – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 14, 2023Select options -
Virus Filtration Market by End User (CROs, Biopharmaceutical, Research), Product (Systems, Kits & Reagents, Services), Application (Water Purification, Biologics, Devices, Air) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 14, 2023Select options -
Human Microbiome Market by Indication (Cancer, Obesity), Application (Diagnostic, Therapeutic), Technology Research (Omics Technologies, HTS), Product (Food, Prebiotics, Drugs), Product Research (Consumables, Instruments)- 2023 to 2028
$3,850.00 – $5,850.00Published on: January 14, 2023Select options -
Cell Expansion Market by Application (Cancer & Cell-based Research, Regenerative Medicine & Stem Cell Research), Product (Centrifuge, Reagent, Media, Flow Cytometer, Bioreactor), Cell Type (Animal, Human), End User, and Region – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 14, 2023Select options -
Immunofluorescence Assay Market by Product (Primary & Secondary Antibody, Reagent, Imaging Equipment, Immunofluorescence Microscopy, Kit), Type (Direct, Indirect), End User – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 14, 2023Select options -
Cell-based Assay Market by Application (Research, Drug Discovery), Product (Cell Lines, Assay Kits, Reagents, Microplates, Instruments, Services), End User (Biopharma Companies, CROs, Research Institutes), Geography – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 14, 2023Select options -
Glycomics / Glycobiology Market by Product (Enzymes (Glycosidase, Glycosyltransferase), Instruments (Mass Spectrometry, HPLS, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Drug Discovery, Diagnostic, Oncology), End User – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 14, 2023Select options -
Cell Signaling Market by Technology (ELISA, Flow Cytometry, Mass Spectrometry) & Application (Cancer, Research, Immunology), Type (Paracrine, Endocrine), Pathway (Notch, Akt, AMPK, Hedgehog), Product (Consumables, Instruments) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 14, 2023Select options -
Antibody Production Market by Process (Downstream Processing, Upstream Processing, and Filtration), End-User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research Institutes) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 14, 2023Select options -
Protein Sequencing Market by Product (Sequencer, Sample Preparation, MS, Consumable, Reagent), Application (Genetic Engineering, Biotherapeutics), Enduser (Biotechnology, Academia, Pharma, CROs) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 14, 2023Select options -
Organs-on-chips Market by End User (Pharma companies, Academic, Research Institute), Type (Heart, Liver, Kidney, Lung, Intestines, Gut), Offering (Service, Product), Application (Physiological model, Toxicity testing) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 14, 2023Select options -
Nerve Repair and Regeneration Market by Application (Stem Cell Therapy, Neurorrhaphy, Nerve Grafting, Neurostimulation Surgery), by Products (Nerve Protectors, Biomaterials, Nerve Conduits, Nerve Wraps, Neurostimulation Devices) – 2023 to 2028
$3,850.00 – $5,850.00Published on: January 13, 2023Select options
The Biotechnology Industry is witnessing an increase in collaborative partnerships with a view to developing newer techniques. During its “green wave” period the industry produced a number of agricultural applications. During its “red wave”, there were a number of developments in the medical space to target disease prevention and management. In its “white wave”, industrial applications were at the forefront. A further rise in demand for therapeutics and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is expected to further fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact rendering growth driver. It is expected to encourage researchers and manufacturers to increase R&D initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalised medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.
Our reports provide application insights, technology insights, regional insights and competitive insights on biomaterials, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology. To know more about our offerings in the Biotechnology market analysis, contact us.
The Biotechnology Industry is witnessing an increase in collaborative partnerships with the primary view of developing newer and pathbreaking technology. The market is set to expand at 9.9 percent CAGR to hit USD 775 billion by 2024 mainly on account of increase in the incidence of chronic diseases such as diabetes and cancer, development of technology innovation and favorable government conditions. The ratio of chronic disease all around the globe is continuously increasing, which is analyzed to propel growth in the industry overall. According to recent data, the estimated number of people affected by the chronic disease will rise to 629 million by 2045. Approximately half of America’s population suffers from at least one chronic disease and this number is growing continuously. These statistics are expected to pave the way for opportunities in the biotechnology market.
The industry has experienced what is known as a ‘wave’ phenomenon. During its ‘green wave’ period the industry produced a number of agricultural applications. During its ‘red wave’, there were a number of developments in the medical space to target disease prevention and management. In its ‘white wave’, industrial applications were at the forefront. A further rise in demand for therapeutic and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is also expected to boost fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact-rendering growth driver. It is expected to encourage researchers and manufacturers to increase research and development initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalized medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.
Global Market Studies’ Biotechnology Market Research reports analysis provide application insights, technology insights, regional insights and competitive insights vis-a-vis the subsectors of biomaterials, biomanufacturing, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology, among others. Key competitor analysis includes that of Agilent Technologies, Amgen, Abbott Laboratories, Bio-Rad Laboratories, BioGen Medical Instruments, Danaher, Merck, F. Hoffmann-La Roche, Illumina, PerkinElmer, Thermo Fisher Scientific and Qiagen.
Contact us at Global Market Studies to know more about our offerings in the Biotechnology sector.